Member Info for Bluelight

I've had worse days ;)

I think what we have is much more media coverage and understanding of the revenue that NCYT is bringing in. This has brought in more investors, both retail and institutional. Given we have limited shares, and many on here wont be in the slightest bit interested in letting them go what with the potential. That creates a bit of a feeding frenzy to get hold of shares. Perfect storm brewing for a big lift off.

Yep I'd go along with that. 50% short term upside as we stand, and more if any of the expected news lands. A good RNS and we'll be touching £20 I would think.

Quite a few reasons we are up today. There was an interview where NCYT was hotly tipped, and GSK named as a suitor (twitter comments discuss that). Ten barrier broken so move towards new higher target levels. Weakness in peers GDR and AVCT, who are both having a shocker for different reasons today. Plus likely buying from institutions, and bullish overall sentiment. What's not to love.

Should take it as a compliment. Such posters usually have an ulterior motive, hoping to buy in cheaper. It's just more people looking to get in. Might have worked if most of us werent sat on hundreds of percent gains, with little interest in selling below fundamental value.

You can also det up a demo account on IG index. No cost, and you can create a live price portfolio of as many shares as you like. I use that for within day pricing.

In fact a cursory look on the ncyt twitter page has multiple links to it, so you shouldn't have a problem accessing it there

Yes looks like the link doesn't work anymore. Keep your eye on Twitter, those guys are the ones who posted the report so no doubt they will update the link later.

It's good to see this is a valuation base don as of now. We are aware they are likely to get a care home contract, and highly likely to get a significant French contract. This would boost that share recommendation very quickly to the blue sky price level in my view. I've previously been saying 12-14 is fair value as of today, so this all ties in with my own view also.

Not sure Shaun to be honest. I posted the existing link from the twitter board. You could argue it is in the public forum now, but I'm not sure how these things work.

"In a blue sky scenario, where the second phase of the DHSC hospital testing contract was exercised in full to its maximum, the total value of the contract could range as high as £850m, which would potentially drive our 2021 revenue forecasts above 1bn at the top end of the range. We see such a scenario as possible given the implicit demand for testing and Novacyt's track record of delivery, and factor this into our valuation with a 10% weighting"

I've never seen a company issue an RNS for a broker report. Broker reports by their very definition are known information, and RNS is just for new price sensitive information, which a broker note is not. The full report looks genuine to me. I've seen hundreds over the years and it looks spot on. It's incredibly detailed.

Here's the full report as just posted on twitter. Haven't read it all yet but looks comprehensive. https://t.co/bIoZCaMV6u?amp=1

You were going to buy back under 8 yesterday. Didn't work so well that strategy... I imagine Tuesday you will be looking to buy under 10.

I don't understand what people are yammering on about a drop, it didn't drop. It closed at 929, and France closed at the equivalent of 934. Google ****ed up a late reported trade which screwed up their pricing view. Seriously people, anyone would think some of you have never invested in shares before. Just look for the UT trade, that's the close price.

It's for a whole range of services from clothes to oxygen, and a whole range of suppliers.

France has just skyrocketed

Damn I wish I'd doubled my holding on the dip down to 750, oh wait.. I did :)

How's that short going Pete? Your attempt to make 1 or 2% ends up costing you 10% eh. That's why you never bet against a fundamentally undervalued company.

You don't have to issue an RNS on a broker note as there's no info in a broker note that isn't already known, if every company did that there would be RNS' coming out of our ears. They are simply analysing the company value and valuing it accordingly in their research.